Insomnia News and Research

Latest Insomnia News and Research

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Researchers work to identify areas of the brain that help us wake up

Philosophers have pondered the nature of consciousness for thousands of years. In the 21st century, the debate over how the brain gives rise to our everyday experience continues to puzzle scientists.

22 Jun 2018

New study finds increase in use of alternative medicines among children

A new study published in JAMA Pediatrics shows that since 2003, the use of alternative medicines, such as herbal products and nutraceuticals, among children has doubled.

19 Jun 2018

Sleep disorders appear to be first sign of serious neurological diseases

Sleep disorders are often the first sign of serious neurological diseases. Neurologists should inquire extensively about the quality of their patients' sleep.

18 Jun 2018

Researchers uncover why people with Parkinson's disease suffer from sleep disturbances

A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances.

8 Jun 2018

Study: 25% of Americans experience acute insomnia every year

About 25 percent of Americans experience acute insomnia each year, but about 75 percent of these individuals recover without developing persistent poor sleep or chronic insomnia, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday at SLEEP 2018, the 32nd Annual Meeting of the Associated Professional Sleep Societies LLC.

6 Jun 2018

Sleep problems associated with decreased work productivity

Preliminary results from a new study suggest that several sleep-related symptoms are associated with decreased work productivity.

4 Jun 2018

Greater screen time linked to insomnia, depressive symptoms among adolescents

Preliminary results from a new study indicate that greater amounts of daily screen time are associated with more insomnia symptoms and shorter sleep duration among adolescents.

4 Jun 2018

Sleep paralysis, hallucinations found to be widespread in student athletes

Pilot data from a recent study suggest that sleep paralysis and dream-like hallucinations as you are falling asleep or waking up are widespread in student athletes and are independently associated with symptoms of depression.

4 Jun 2018

Stroke patients more likely to suffer from insomnia, shows study

Stroke patients experience sustained problems with insomnia potentially reducing their ability to relearn key skills and putting them at increased risk of depression, a new study in the journal Scientific Reports finds.

30 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom withdrawal symptoms in adults in whom the drugs have been withdrawn abruptly.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Overwhelming stress levels in Britain

According to a latest survey by the Mental Health Foundation, there is overwhelming stress that is being experienced by three quarters of Scots last year. The survey shows that a third of these people (over 35 percent) are suicidal due to the excessive stress that they are experiencing.

14 May 2018

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Data from a new survey show that as many as 80% of oncologists have discussed medical marijuana use with their patients.

11 May 2018

New Facebook app provides much-needed support to unpaid caregivers of Alzheimer's patients

Researchers at IUPUI have developed a Facebook app that, a study shows, offers a way to provide much-needed support to unpaid caregivers of people with Alzheimer's disease.

10 May 2018

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

A new experimental study has tested the safety and effectiveness of MDMA-assisted psychotherapy in 26 service personnel with post-traumatic stress disorder (PTSD).

2 May 2018

American Academy of Sleep Medicine selects 2018 award recipients

Several leaders in the field of sleep medicine and a best-selling author were selected as recipients of the 2018 American Academy of Sleep Medicine awards, which will be presented Monday, June 4, during the plenary session of SLEEP 2018, the 32nd annual meeting of the Associated Professional Sleep Societies, LLC in Baltimore.

27 Apr 2018

Insomnia News and Research

Latest Insomnia News and Research

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Researchers work to identify areas of the brain that help us wake up

New study finds increase in use of alternative medicines among children

Sleep disorders appear to be first sign of serious neurological diseases

Researchers uncover why people with Parkinson's disease suffer from sleep disturbances

Study: 25% of Americans experience acute insomnia every year

Sleep problems associated with decreased work productivity

Greater screen time linked to insomnia, depressive symptoms among adolescents

Sleep paralysis, hallucinations found to be widespread in student athletes

Stroke patients more likely to suffer from insomnia, shows study

Celgene to share new and updated data around novel hematological therapies

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Overwhelming stress levels in Britain

New survey shows 80% of oncologists have discussed medical marijuana use with patients

New Facebook app provides much-needed support to unpaid caregivers of Alzheimer's patients

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

American Academy of Sleep Medicine selects 2018 award recipients

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Insomnia News and Research

Latest Insomnia News and Research

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Newsletters you may be interested in